Home / Inspections / 1222303

FDA Inspection 1222303 — Greiner Bio-One North America, Inc.

Greiner Bio-One North America, Inc. — FEI 3001451379

The FDA completed an inspection of Greiner Bio-One North America, Inc. on September 14, 2023 in Monroe, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Monroe, NC (United States)

Facility

Other inspections at this facility

  • 1155664 (VAI Fri Oct 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1114241 (OAI Fri Dec 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021970 (NAI Thu Aug 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 843981 (VAI Wed Jul 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 703137 (NAI Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources